Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.
A retrospective study of 136 bone marrow aspirates was undertaken before treatment to evaluate the importance of bone marrow eosinophilia in Hodgkin's disease. This occurred in 28 patients (21%) but did not correlate with age, sex, B symptoms, histopathological type or peripheral blood count. It also had no effect on survival. Bone marrow eosinophilia, therefore, seems to represent a common but non-specific reaction to Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D001855:Bone Marrow Diseases / Q000209:etiology* / Q000401:mortality; D001856:Bone Marrow Examination; D004802:Eosinophilia / Q000209:etiology* / Q000401:mortality; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies